Weighted Average Number of Shares Outstanding, Basic of IOVANCE BIOTHERAPEUTICS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
IOVANCE BIOTHERAPEUTICS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • IOVANCE BIOTHERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 357,345, a 23% increase year-over-year.
  • IOVANCE BIOTHERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 357,345, a 23% increase from 2024.
  • IOVANCE BIOTHERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 289,877, a 23% increase from 2023.
  • IOVANCE BIOTHERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 235,131, a 48% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 357,345 +67,468 +23% 01 Oct 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 364,037 +60,768 +20% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 334,511 +49,694 +17% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 322,868 +56,648 +21% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 289,877 +54,746 +23% 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 303,269 +57,452 +23% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 284,817 +60,336 +27% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 266,220 -213,427,780 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 235,131 +75,872 +48% 01 Oct 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
Q3 2023 245,817 -157,571,183 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 224,481 -157,049,519 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 213,694,000* +56,581,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 159,259 +5,853 +3.8% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 157,817,000* +2,309,000 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 157,274,000* +3,523,000 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 157,113,000* +156,965,630 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 153,406 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 155,508,000* +155,361,508 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 153,751,000* 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 147,370 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q3 2020 146,492 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3

IOVANCE BIOTHERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 357,345 +67,468 +23% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 289,877 +54,746 +23% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 235,131 +75,872 +48% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 159,259 +5,853 +3.8% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 153,406 +15,105 +11% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 138,301 +13,965 +11% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 124,336 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.